Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dysport intravesical injection for neurogenic detrusor overactivity
2005-004996-40Phase 2Terminated
- Sponsor
- Cardiff and Vale University Health Board
- Start
- Jan 2006
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of botulinum toxin type A in detrusor hyperreflexia (DH), sponsored by Cardiff and Vale University Health Board. Primary endpoint: Change in quality of life and symptomatology score at Week 6. Started Jan 2006; status: terminated.
02
Drugs
botulinum toxin type A
03
Conditions
detrusor hyperreflexia (DH)
Beyond the preview
Go deeper on 2005-004996-40.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-004996-40.